SCHEMBL8846909

SCHEMBL8846909

CC(c1ccccc1)c1ccccc1OC(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 1/20 0.42
HPGD P15428 3/20 0.41
KDM4E B2RXH2 3/20 0.41
HSD17B10 Q99714 3/20 0.41
ALDH1A1 P00352 2/20 0.41
PTGS1 P23219 2/20 0.41
PTGS2 P35354 2/20 0.41
TSHR P16473 2/20 0.41
ESR1 P03372 1/20 0.41
ITGB3 P05106 1/20 0.41
ITGA2B P08514 1/20 0.41
HMGB1 P09429 1/20 0.41
GGT1 P19440 1/20 0.41
BLM P54132 1/20 0.41
NAPRT Q6XQN6 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
KMT2A Q03164 2/20 0.39
L3MBTL1 Q9Y468 3/20 0.38
POLB P06746 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL868867 0.89 PTGS2 (0.53) TYRHPGDKDM4EHSD17B10ALDH1A1
SCHEMBL9979219 0.83 TSHR (0.49) HPGDKDM4EHSD17B10ALDH1A1PTGS1
SCHEMBL25272705 0.83 ESR1 (0.40) HPGDKDM4EHSD17B10ALDH1A1PTGS1
SCHEMBL10524187 0.80 KDM4E (0.42) HPGDKDM4EHSD17B10ALDH1A1PTGS1
SCHEMBL1790171 0.80 KDM4E (0.42) HPGDKDM4EHSD17B10ALDH1A1PTGS1
SCHEMBL29655932 0.80 KDM4E (0.42) HPGDKDM4EHSD17B10ALDH1A1PTGS1
SCHEMBL10541465 0.79 TYR (0.46) TYRHPGDKDM4EHSD17B10ALDH1A1
SCHEMBL17386335 0.79 TYR (0.40) TYRHPGDKDM4EHSD17B10ALDH1A1
SCHEMBL15899545 0.79 HPGD (0.38) HPGDKDM4EHSD17B10ALDH1A1PTGS1
SCHEMBL5941442 0.79 IDO1 (0.56) TYRHPGDALDH1A1PTGS1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5643926-A Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof ELI LILLY AND COMPANY (US) 1997-07-01 US disclosed
US-5399565-A Treatment of psychological, central nervous system and gastrointestinal disorders ELI LILLY AND COMPANY (US) 1995-03-21 US disclosed
US-5300514-A Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof ELI LILLY AND COMPANY (US) 1994-04-05 US disclosed